KE Sharquie, AA Noaimi, BAM Saleh, 2015
KE Sharquie, HR Al-Hamamy, AA Noaimi, KA Ali, Journal of Cosmetics, Dermatological Sciences and Applications, 2015 - Cited by 3
KE Sharquie, AA Noaimi, WK Al-Janabi, The Iraqi Postgraduate Medical Journal, 2013 - Cited by 3
HR Al-Hamamy, AA Noaimi, HA Salman, NAA Jabbar, American Journal of Dermatology and Venereology, 2013
KE Sharquie, AA Noaimi, Journal of the Saudi Society of Dermatology & Dermatologic Surgery, 2012 - Cited by 36
KE Sharquie, SA Al-Mashhadani, AA Noaimi, AA Hasan, Journal of Cutaneous and Aesthetic Surgery, 2012 - Cited by 19
KE Sharquie, AA Noaimi, WK Al-Janabi, Journal of Cosmetics, Dermatological Sciences and Applications, 2013
HR Al-Hamamy, KE Sharquie, AA Noaimi, WN Hussein, Our Dermatology Online, 2014 - Cited by 6
Iraqi species of mistletoe (Loranthus europaeus) have been used in the present study to evaluate genotoxicy of aqueous fraction in two doses (200mg/kg and 400mg/kg) on bone marrow cells in mice for seven successive days, comparing their effects with a (methotrexate). 200mg/kg of extract of L.europeaus significantly decrease mitotic index (P<0.05), while 400mg/kg none significantly increase this parameter compared to control group. For chromosomal aberration, the aqueous fraction of L.europeaus (in both doses) produced significant increase at dose of 200mg/kg and none significantly increase at a dose 400mg/kg in this marker compared to control (P<0.05) Meanwhile, 20mg/kg methotrexate significantly increases chromosomal aberration compared to
... Show MoreKE Sharquie, JR Al-Rawi, AA Noaimi, HM Al-Hassany, Journal of drugs in dermatology: JDD, 2012 - Cited by 47
KE Sharquie, AA Khorsheed, AA Al-Nuaimy, Saudi Medical Journal, 2007 - Cited by 91